Skip to content
Mivacurium chloride
Mivacron (mivacurium chloride) is a small molecule pharmaceutical. Mivacurium chloride was first approved as Mivacron on 1992-01-22.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Mivacurium chloride
Tradename
Company
Number
Date
Products
MIVACRONAbbVieN-020098 DISCN1992-01-22
1 products, RLD
MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINERAbbVieN-020098 DISCN1992-01-22
2 products
MIVACRONAbbVieN-020098 DISCN1992-01-22
2 products, RLD
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
M: Musculo-skeletal system drugs
— M03: Muscle relaxants
— M03A: Muscle relaxants, peripherally acting agents
— M03AC: Other quaternary ammonium compounds in atc, muscle relaxants, peripherally acting
— M03AC10: Mivacurium chloride
HCPCS
No data
Clinical
Clinical Trials
296 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Myeloid leukemia acuteD015470C92.04240162185
Precursor cell lymphoblastic leukemia-lymphomaD054198C91.091223—22
Promyelocytic leukemia acuteD015473C92.4——33—6
Neuromyelitis opticaD009471EFO_0004256G36.0—1—2—3
Autoimmune diseases of the nervous systemD020274———1—1
Transverse myelitisD009188G37.3———1—1
Cns demyelinating autoimmune diseasesD020278EFO_1000870G37———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LeukemiaD007938C95132216—148
Prostatic neoplasmsD011471C616198——29
LymphomaD008223C85.931111—124
Myelodysplastic syndromesD009190D4611115——23
Monocytic leukemia acuteD007948761——12
Myeloid leukemiaD007951C92551——10
Breast neoplasmsD001943EFO_0003869C50—63——9
NeoplasmsD009369C80711——8
Large b-cell lymphoma diffuseD016403C83.3161——7
Eyelid neoplasmsD005142EFO_1000934231——6
Show 12 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Myelomonocytic leukemia acuteD015479C92.575———11
Erythroblastic leukemia acuteD004915EFO_1001257C94.075———11
Megakaryoblastic leukemia acuteD007947C94.274———10
Non-hodgkin lymphomaD008228C85.937———9
Biphenotypic leukemia acuteD015456C95.033———4
Mantle-cell lymphomaD020522C83.1—3———3
Relapsing-remitting multiple sclerosisD020529EFO_0003929—3———3
Basophilic leukemia acuteD015471C94.811———2
Eosinophilic leukemia acuteD01547211———2
Myelomonocytic leukemia chronicD015477C93.111———2
Show 16 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Stomach neoplasmsD013274EFO_0003897C161————1
Liver neoplasmsD008113EFO_1001513C22.01————1
Head and neck neoplasmsD0062581————1
SarcomaD0125091————1
Multiple myelomaD009101C90.01————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Drug therapyD004358————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameMIVACURIUM CHLORIDE
INNmivacurium chloride
Description
Mivacurium chloride (formerly recognized as BW1090U81, BW B1090U or BW1090U) is a short-duration non-depolarizing neuromuscular-blocking drug or skeletal muscle relaxant in the category of non-depolarizing neuromuscular-blocking drugs, used adjunctively in anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
Classification
Small molecule
Drug classquaternary ammonium derivatives: neuromuscular blocking agents
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
COc1cc2c(cc1OC)[C@@H](Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CC/C=C/CCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3[C@H]1Cc1cc(OC)c(OC)c(OC)c1)CC2.[Cl-].[Cl-]
Identifiers
PDB—
CAS-ID106861-44-3
RxCUI—
ChEMBL IDCHEMBL984
ChEBI ID—
PubChem CID71316
DrugBankDB01226
UNII ID600ZG213C3 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 697 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
6,331 adverse events reported
View more details